That is the title of an interesting panel from USC Schaeffer Center on Coverage with Evidence Development (CED). It includes an interview with Tamara Syrek Jensen, Director, of the Coverage & Analysis Group within the Centers for Medicare & Medicaid Services. After the interview, there is a panel discussion of academics with Darius Lakdawalla of USC, Peter Neumann of Tufts University, and Joshua Makower of Stanford University. A second panel includes a diverse set of healthcare stakeholders including Gregory Daniel, Vice President, Global Public Policy Eli Lilly; John Dwyer, Co-Founder and President of the Global Alzheimer’s Platform Foundation; Perry Bridger, Senior Advisor of Public Affairs at Edwards Lifesciences’ and Robert McDonough Senior Director for Clinical Policy Research and Development at Aetna. The video of the full panel is below.
What do you think of CMS’s approach to Coverage with Evidence Development?
Disclaimer :
This article is solely for informational purposes, any medical information contained is not a substitute for professional medical advice and readers should not rely on it as such.
If you believe there may be errors or misinformation in this article, we encourage you to contact the webmasters by messaging the provided contact information.
Your feedback is valuable, and we are committed to rectifying any inaccuracies. Please note that the content will be re-evaluated, and corrections will be made as necessary following your submission.